Charles Burns, MD
Family Practice · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Offices
- 2
- Since medical school
- 50 years
- University of California, San Francisco School of Medicine, 1976
Offices
2 locations · One Medical Group Inc · 330 clinicians in this group
Looking this up.
Hospitals listed: California Pacific Medical Center- Van Ness Campus. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Burns’s office at (888) 663-6331 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence G46294 · Current
Licensed to practise in California · since 2011 · expires 2027-12-31 · University of California San Francisco School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- California Pacific Medical Center- Van Ness CampusSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.224, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.325, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.373, Oct 2024 – Sep 2025
See every measure and the patient survey for California Pacific Medical Center- Van Ness Campus
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.224 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.325 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.373 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.14 (0.3 to 1.97) · 2,271 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.81 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.86 (151.51 to 234.22) · 140 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10.3 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.5 · 143 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.8 · 356 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.3 · 259 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 173 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,316 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.31 (0.12 to 0.49) · 6,430 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.09 to 0.47) · 7,168 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.3 (1.5 to 5.09) · 2,196 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.47 (1.21 to 3.74) · 925 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.63 (1.37 to 3.88) · 1,954 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.13 (6.06 to 14.2) · 1,112 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.26 (4.67 to 9.85) · 1,084 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.31 to 3.03) · 832 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.33 (0 to 0.85) · 5,406 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0.443 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.717 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 200 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 449 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 18.2 · 187 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 8.7 · 418 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.1 · 260 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.2 · 293 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.6 to 7.6) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.2 (7.7 to 13.5) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 11 · 33 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 66 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.4 to 16.7) · 551 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.3) · 219 cases | No different | Jan 2024 – Dec 2024 |
What patients said (478 patients answered, 20% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$12,773
Medicare paid this office $12,773 for 67 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 34 | $3,167 | $63 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 14 | $2,178 | $156 |
| Return visit (30+ min) | 21 | $2,080 | $80 |
| Insertion of needle into vein for collection of blood sample | 31 | $320 | $9 |
Who their Medicare patients are
67 Original Medicare patients in 2024. Average age 73 · Women 28% · Health risk score 0.57. At or below the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 43%.
The office billed $93,183, Medicare allowed $18,373 and paid $12,773; for 193 services of 22 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 67 | 193 | 73 | 0.57 | $93,183 | $12,773 |
| 2023 | 79 | 211 | 72 | 0.69 | $110,604 | $16,609 |
| 2022 | 54 | 107 | 73 | 0.54 | $57,660 | $8,956 |
| 2021 | 64 | 120 | 72 | 0.82 | $60,080 | $10,952 |
| 2020 | 51 | 78 | 72 | 0.55 | $29,100 | $4,684 |
| 2019 | 45 | 86 | 72 | 0.62 | $35,420 | $6,304 |
| 2018 | 42 | 80 | 71 | 0.63 | $28,660 | $5,209 |
| 2017 | 40 | 89 | 71 | 0.58 | $28,400 | $5,526 |
| 2016 | 26 | 62 | 70 | 0.80 | $28,041 | $5,324 |
| 2015 | 21 | 54 | 71 | 1.09 | $18,302 | $4,255 |
| 2014 | 34 | 60 | 68 | 0.69 | $19,240 | $4,508 |
| 2013 | 38 | 74 | 65 | 0.69 | $23,589 | $5,607 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Return visit (30+ min) | 31 | $4,907 | $107 |
| Short return visit (20+ min) | 28 | $3,775 | $77 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 18 | $2,753 | $153 |
| Short return visit | 13 | $586 | $45 |
| Insertion of needle into vein for collection of blood sample | 25 | $235 | $8 |
2022: 3 services
| Short return visit (20+ min) | 32 | $2,932 | $67 |
| Return visit (30+ min) | 13 | $2,109 | $100 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 13 | $2,009 | $155 |
2021: 3 services
| Return visit (30+ min) | 14 | $2,574 | $123 |
| Short return visit (20+ min) | 28 | $2,440 | $68 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 13 | $2,038 | $157 |
2020: 2 services
| Return visit (30+ min) | 18 | $1,433 | $68 |
| Short return visit (20+ min) | 14 | $895 | $56 |
2019: 3 services
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 15 | $2,056 | $137 |
| Return visit (30+ min) | 18 | $1,680 | $73 |
| Short return visit (20+ min) | 14 | $1,235 | $56 |
2018: 3 services
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 13 | $1,727 | $133 |
| Return visit (30+ min) | 12 | $1,142 | $71 |
| Short return visit (20+ min) | 16 | $880 | $46 |
2017: 4 services
| Return visit (30+ min) | 15 | $1,866 | $81 |
| Influenza vaccine split virus, preservative free | 13 | $625 | $48 |
| Short return visit (20+ min) | 14 | $586 | $39 |
| Administration of influenza virus vaccine | 14 | $453 | $32 |
2016: 1 service
| Return visit (30+ min) | 16 | $2,518 | $87 |
2015: 1 service
| Return visit (30+ min) | 13 | $1,998 | $91 |
2014: 2 services
| Return visit (30+ min) | 17 | $2,485 | $86 |
| Short return visit (20+ min) | 13 | $932 | $55 |
2013: 2 services
| Return visit (30+ min) | 16 | $2,395 | $89 |
| Short return visit (20+ min) | 11 | $1,145 | $55 |
Drugs they prescribed that Part D paid
$22,464
Pharmacies billed $22,464 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
248 generic and 52 brand-name prescriptions · $22,464 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Synthroid | 14 | $1,252 | $89 |
| Atorvastatin | 37 | $526 | $14 |
| Metoprolol | 18 | $242 | $13 |
| Losartan | 13 | $49 | $4 |
| Lisinopril | 11 | $42 | $4 |
See all 6 drugs
| Synthroid | 14 | $1,252 | $89 |
| Atorvastatin | 37 | $526 | $14 |
| Metoprolol | 18 | $242 | $13 |
| Losartan | 13 | $49 | $4 |
| Lisinopril | 11 | $42 | $4 |
| Zolpidem | 12 | $25 | $2 |
Year by year
| 2024 | 300 | 54 | None | 17% | $22,464 |
| 2023 | 308 | 55 | 4% (11) | None | $19,718 |
| 2022 | 194 | 37 | None | None | $21,350 |
| 2021 | 164 | 42 | 9% (15) | 15% | $16,968 |
| 2020 | 115 | 25 | 10% (12) | 13% | $9,416 |
| 2019 | 105 | 22 | None | 11% | $5,796 |
| 2018 | 111 | 19 | None | 16% | $4,387 |
| 2017 | 104 | 19 | None | 18% | $2,690 |
| 2016 | 129 | 22 | None | 9% | $5,740 |
| 2015 | 98 | 15 | None | 24% | $9,399 |
| 2014 | 179 | 28 | 0% (0) | None | $15,461 |
| 2013 | 175 | 48 | None | None | $6,198 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 5 drugs
| Synthroid | 12 | $1,220 | $102 |
| Atorvastatin | 24 | $481 | $20 |
| Rosuvastatin | 23 | $272 | $12 |
| Lisinopril | 16 | $152 | $10 |
| Zolpidem | 13 | $64 | $5 |
2022: 1 drug
| Atorvastatin | 13 | $138 | $11 |
2021: 2 drugs
| Atorvastatin | 15 | $183 | $12 |
| Lorazepam | 12 | $33 | $3 |
2020: 1 drug
| Tramadol | 11 | $41 | $4 |
2019: 1 drug
| Atorvastatin | 15 | $394 | $26 |
2018: 1 drug
| Tamsulosin | 13 | $599 | $46 |
2017: 1 drug
| Simvastatin | 15 | $60 | $4 |
2016: 2 drugs
| Simvastatin | 15 | $74 | $5 |
| Lisinopril | 13 | $70 | $5 |
2015: 2 drugs
| Fluticasone Propionate | 11 | $148 | $13 |
| Lisinopril | 11 | $38 | $3 |
2014: 2 drugs
| Fluticasone Propionate | 13 | $292 | $22 |
| Lisinopril | 12 | $66 | $6 |
2013: 3 drugs
| Lisinopril | 14 | $194 | $14 |
| Mirtazapine | 12 | $168 | $14 |
| Atenolol | 16 | $127 | $8 |
Money from drug and device companies
$17 in 2023
A payment is not proof that care is biased.
| ViiV Healthcare | Apretude | $17 | 1 payment
|
See the published payment
| ViiV Healthcare | Education · 2023-02-15 | Apretude | $17 |
Professional record
- NPI
- 1588651582
- Licence
- CA G 46294, ME 010198California G46294: Current · expires 2027-12-31
- Trained
- University of California, San Francisco School of Medicine, 1976 · 50 years ago
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- ME 336820099
- Taxonomy
- Federal specialty code 207QA0505X (207QA0505X); Family medicine (207Q00000X)
- Mailing address
- Po Box 779, San Francisco, CA, 94104
- NPI first listed
- 2005-10-04
- NPI last updated
- 2012-08-13
This is when the NPI record was last certified, not a medical board exam.